Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
am I too late to get the second dose now that it's May, 2025; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient had first Shingrix shot in September of 2024). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: am I too late to get the second dose now that it's May, 2025). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 09-MAY-2025 Patient stated that they had first Shingrix shot in September of 2024; and asked whether its too late to get the second dose as it was May, 2025. Till the time of reporting patient did not receive second dose of vaccination which led to incomplete course of vaccination.